sulfadiazine has been researched along with Burns in 184 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
Burns: Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We conducted this clinical trial to evaluate the period of wound healing with sea buckthorn dressings for the second-degree burns and compare the results with 1% silver sulfadiazine (SSD) dressings." | 9.41 | To compare the effect of sea buckthorn and silver sulfadiazine dressing on period of wound healing in patients with second-degree burns: A randomized triple-blind clinical trial. ( Abdullahzadeh, M; Shafiee, S, 2021) |
| "A randomized, prospective study comparing the use of Biobrane (group 1) with the use of 1% silver sulfadiazine (group 2) in treating 56 partial-thickness burn wounds was carried out in 52 outpatients with burns that comprised less than 10% of their total body surface area." | 9.06 | Outpatient management of partial-thickness burns: Biobrane versus 1% silver sulfadiazine. ( Effron, D; Emerman, CL; Fratianne, RB; Gerding, RL; Imbembo, AL; Lukens, T, 1990) |
| "When used appropriately on superficial or moderate-depth partial-thickness burns, Biobrane significantly decreased total healing time to complete reepithelialization, reduced pain, and was associated with decreased nursing time and costs when compared to 1% silver sulfadiazine cream." | 9.06 | Biosynthetic skin substitute vs. 1% silver sulfadiazine for treatment of inpatient partial-thickness thermal burns. ( Fratianne, RB; Gerding, RL; Imbembo, AL, 1988) |
| "The purpose of this prospective randomized study was to evaluate the use of an occlusive hydrocolloid dressing (Duoderm hydroactive, Squibb) and silver sulfadiazine (Silvadene, Marion) cream in the outpatient management of second-degree burns." | 9.06 | Comparison of a hydrocolloid dressing and silver sulfadiazine cream in the outpatient management of second-degree burns. ( McGowan, DN; Najarian, MP; Wyatt, D, 1990) |
| "The relationship of silver sulfadiazine therapy to leukopenia has been controversial." | 9.05 | Leukopenia and silver sulfadiazine. ( Bingham, HG; Caffee, HH, 1982) |
| "In a prospective, randomized study of patients with major burns, the efficacy of cerium nitrate-silver sulfadiazine cream was compared with that of silver sulfadiazine cream alone." | 9.05 | Cerium nitrate-silver sulfadiazine cream in the treatment of burns: a prospective evaluation. ( Helvig, E; Munster, AM; Rowland, S, 1980) |
| "In a prospective, randomized study of 34 patients with thermal burns, treatment with the topical agent Cerium nitrate-silver sulfadiazine was compared with therapy with silver sulfadiazine alone." | 9.04 | Cerium nitrate-silver sulfadiazine cream in the treatment of burns: a prospective, randomized study. ( Helvig, EI; Munster, AM; Oppel, W; Su, CT, 1979) |
| " Objective of this study was to compare the efficacy of collagen sheets and 1% silver sulfadiazine dressing (SSD) for superficial partial thickness burns." | 8.12 | A Comparative Study of Collagen Sheet versus 1% Silver Sulfadiazine Dressing in Superficial Partial Thickness Burns. ( Ali, A; Anam, S; Bhuiyan, MH; Dhar, LK; Hossain, MA; Jahan, I; Kaiser, A; Razia, S; Sarker, B; Satter, T; Talukder, A, 2022) |
| "This study was performed in order to investigate serum and tissue silver levels in burns which were used 10 percent silver nitrate as a topical agent." | 7.67 | [Serum and tissue silver levels after burns treated with silver compounds]. ( Belviranli, M; Duman, S; Gurbilek, M; Karahan, O; Kartal, A; Sahin, M; Tatkan, Y; Temur, S, 1989) |
| "All patients hospitalized between May 1987 and June 1988 suffering from burns covering over 50 per cent of the body surface area were treated by topical application of a cream containing cerium nitrate (0." | 7.67 | Use of topically applied silver sulphadiazine plus cerium nitrate in major burns. ( Guelfi, MC; Lebreton, F; Levy, J; Schlotterer, M; Wassermann, D, 1989) |
| "Leukopenia associated with silver sulfadiazine (SSD) is a frequent event and may be a risk factor for infectious complications in the burn patient." | 7.67 | Leukopenia secondary to silver sulfadiazine: frequency, characteristics and clinical consequences. ( Choban, PS; Marshall, WJ, 1987) |
| "05 per cent chlorhexidine for bathing burn wounds or the topical application of a cream containing cerium nitrate and silver sulphadiazine showed that the cerium-flamazine cream significantly reduced the degree of Pseudomonas aeruginosa contamination of the burn wounds of patients with burns covering more than 15 per cent of the body surface area." | 7.67 | Bacteriological effect of cerium-flamazine cream in major burns. ( Boeckx, W; Cornelissen, M; Focquet, M; Nuttin, B, 1985) |
| "Of 68 burn patients at the University of Wisoncsin Burn Center treated with silver sulfadiazine cream over 2 years, two (about 3%) developed fever and marked leukopenia." | 7.65 | Acute leukopenia as an allergic reaction to silver sulfadiazine in burn patients. ( Chan, CK; Jarrett, F; Moylan, JA, 1976) |
| "Nitrofurazone (N), povidone-iodine (P), and silver sulfadiazine (S) were compared in the emergency department outpatient treatment of 84 patients suffering second degree burns over less than 15% (adults) or 5% (children) of their total body surface area." | 7.65 | Treatment of second degree burns: nitrofurazone, povidone-iodine, and silver sulfadiazine. ( Crenshaw, CA; Glanges, E; Webber, CE, 1977) |
| "Zinc sulfadiazine is a new compound which is effective in vitro and in vivo against Pseudomonas aeruginosa infections in burned mice and rats." | 5.26 | Zinc sulfadiazine for topical therapy of pseudomonas infection in burns. ( Fox, CL; Modak, SM; Stanford, JW, 1976) |
| " We describe a prospective randomized pilot study comparing Mepitel to the standard silver sulfadiazine cream (Flamazine) dressing for the topical treatment of paediatric burns." | 5.08 | A silicone-coated nylon dressing reduces healing time in burned paediatric patients in comparison with standard sulfadiazine treatment: a prospective randomized trial. ( Birraux, J; Bugmann, P; Genin, B; Gyger, D; La Scala, G; Le Coultre, C; Lironi, A; Taylor, S; Vunda, A, 1998) |
| "A randomized, prospective study comparing the use of Biobrane (group 1) with the use of 1% silver sulfadiazine (group 2) in treating 56 partial-thickness burn wounds was carried out in 52 outpatients with burns that comprised less than 10% of their total body surface area." | 5.06 | Outpatient management of partial-thickness burns: Biobrane versus 1% silver sulfadiazine. ( Effron, D; Emerman, CL; Fratianne, RB; Gerding, RL; Imbembo, AL; Lukens, T, 1990) |
| "The relationship of silver sulfadiazine therapy to leukopenia has been controversial." | 5.05 | Leukopenia and silver sulfadiazine. ( Bingham, HG; Caffee, HH, 1982) |
| "Compared to nonoperative treatment with silver sulfadiazine cream, early excision and grafting of 22 patients with indeterminant burns of less than 20% TBSA resulted in an average shorter hospitalization, lower cost, and less time away from work than 25 patients treated nonoperatively." | 5.05 | Early excision and grafting vs. nonoperative treatment of burns of indeterminant depth: a randomized prospective study. ( Engrav, LH; Harnar, TJ; Heimbach, DM; Marvin, JA; Reus, JL, 1983) |
| "Previous studies have indicated that combining cerium nitrate with silver sulfadiazine (Silvadene, Marion Labs) yields a superior topical agent for the treatment of burns." | 5.05 | A prospective analysis of silver sulfadiazine with and without cerium nitrate as a topical agent in the treatment of severely burned children. ( Bowser, BH; Caldwell, FT; Cone, JB; Eisenach, KD; Thompson, CH, 1981) |
| "In a prospective, randomized study of patients with major burns, the efficacy of cerium nitrate-silver sulfadiazine cream was compared with that of silver sulfadiazine cream alone." | 5.05 | Cerium nitrate-silver sulfadiazine cream in the treatment of burns: a prospective evaluation. ( Helvig, E; Munster, AM; Rowland, S, 1980) |
| "In a prospective, randomized study of 34 patients with thermal burns, treatment with the topical agent Cerium nitrate-silver sulfadiazine was compared with therapy with silver sulfadiazine alone." | 5.04 | Cerium nitrate-silver sulfadiazine cream in the treatment of burns: a prospective, randomized study. ( Helvig, EI; Munster, AM; Oppel, W; Su, CT, 1979) |
| "2% chlorhexidine digluconate (SNC) showed that all were comparably effective in protecting burns from infection." | 5.04 | Topical chemoprophylaxis with silver sulphadiazine and silver nitrate chlorhexidine creams: emergence of sulphonamide-resistant Gram-negative bacilli. ( Babb, JR; Bridges, K; Jackson, DM; Lowbury, EJ, 1976) |
| " They may occasionally perforate, resulting in the release of sodium azide or sodium hydroxide, which result in chemical burns when in contact with skin." | 4.82 | Burn injuries resulting from (accidental) airbag inflation. ( Kreusch, T; Suhr, M, 2004) |
| " Objective of this study was to compare the efficacy of collagen sheets and 1% silver sulfadiazine dressing (SSD) for superficial partial thickness burns." | 4.12 | A Comparative Study of Collagen Sheet versus 1% Silver Sulfadiazine Dressing in Superficial Partial Thickness Burns. ( Ali, A; Anam, S; Bhuiyan, MH; Dhar, LK; Hossain, MA; Jahan, I; Kaiser, A; Razia, S; Sarker, B; Satter, T; Talukder, A, 2022) |
| "Here we report two cases of high silver concentrations in biological samples in two women: the first patient presented grey marks around her cuticles, probably due to her consumption of silvered sweets and the second patient presented agranulocytosis and thrombocytopenia occurring within 24 h after the topical application of a cream containing sulfadiazine and silver to burns over a large surface area." | 4.02 | High silver concentrations in biological samples following different exposures: Two case reports. ( Cazaubon, Y; Cohen, B; Colonna, G; Darrouzain, F; Deguigne, M; Leccia, F; Lelievre, B; Tellier, AC, 2021) |
| "In the present study chitosan based gel formulations containing Egg Yolk Oil (EYO) and Epidermal Growth Factor (EGF) were formulated successfully aiming at enhanced topical treatment of dermal burns the combination of traditional approaches with modern drug delivery systems." | 3.81 | Chitosan gel formulations containing egg yolk oil and epidermal growth factor for dermal burn treatment. ( Arslan, R; Başaran, E; Bayçu, C; Berkman, MS; Güven, UM; Yazan, Y; Yenilmez, E, 2015) |
| "To compare infection and reepithelialization rates of contaminated second-degree burns treated with octylcyanoacrylate (OCA), silver sulfadiazine (SSD), polyurethane (PU) film, and dry gauze (control; C) in swine." | 3.70 | Octylcyanoacrylate for the treatment of contaminated partial-thickness burns in swine: a randomized controlled experiment. ( McClain, SA; Mohammad, M; Singer, AJ; Thode, HC; Tortora, G, 2000) |
| "This study was performed in order to investigate serum and tissue silver levels in burns which were used 10 percent silver nitrate as a topical agent." | 3.67 | [Serum and tissue silver levels after burns treated with silver compounds]. ( Belviranli, M; Duman, S; Gurbilek, M; Karahan, O; Kartal, A; Sahin, M; Tatkan, Y; Temur, S, 1989) |
| "All patients hospitalized between May 1987 and June 1988 suffering from burns covering over 50 per cent of the body surface area were treated by topical application of a cream containing cerium nitrate (0." | 3.67 | Use of topically applied silver sulphadiazine plus cerium nitrate in major burns. ( Guelfi, MC; Lebreton, F; Levy, J; Schlotterer, M; Wassermann, D, 1989) |
| "Leukopenia associated with silver sulfadiazine (SSD) is a frequent event and may be a risk factor for infectious complications in the burn patient." | 3.67 | Leukopenia secondary to silver sulfadiazine: frequency, characteristics and clinical consequences. ( Choban, PS; Marshall, WJ, 1987) |
| " Topical treatment with silver sulfadiazine was associated with more significant leukopenia and neutropenia than treatment with silver nitrate." | 3.67 | The clinical consequences of an industrial aerosol plant explosion. ( Burke, J; Grindlinger, GA; Hirsch, EF; Hull, D; Petrone, S, 1985) |
| "05 per cent chlorhexidine for bathing burn wounds or the topical application of a cream containing cerium nitrate and silver sulphadiazine showed that the cerium-flamazine cream significantly reduced the degree of Pseudomonas aeruginosa contamination of the burn wounds of patients with burns covering more than 15 per cent of the body surface area." | 3.67 | Bacteriological effect of cerium-flamazine cream in major burns. ( Boeckx, W; Cornelissen, M; Focquet, M; Nuttin, B, 1985) |
| "This report demonstrates prolonged effective release of silver sulfadiazine (AgSD) to experimental burns in rats from a solid dressing by mixtures of polyethylene glycol-400 and poly-2-hydroxyethyl methacrylate." | 3.66 | Control of experimental burn wound infections: comparative delivery of the antimicrobial agent (silver sulfadiazine) either from a cream base or from a solid synthetic dressing. ( Nathan, P; Robb, EC, 1981) |
| "The attachment of Ag110-labeled sulfadiazine silver (AgSU) to the burn wound of humans and full and partial thickness scald burns of rats was studied over time." | 3.66 | Pharmacology of sulfadiazine silver. Its attachment to burned human and rat skin and studies of gastrointestinal absorption and extension. ( Harrison, HN, 1979) |
| "The pathophysiology, classification and bacteriology of burns are discussed, as well as treatment of burns with silver nitrate, silver sulfadizine, silver allantoinate, mafenide acetate, furazolium chloride, povidone-iodine complex, antibiotics, antiproteolytics, fibrinolytics, Pseudomonas vaccine and antiglobulins." | 3.65 | Topical treatment of the burn patient. ( Lunan, HN, 1975) |
| "Of 68 burn patients at the University of Wisoncsin Burn Center treated with silver sulfadiazine cream over 2 years, two (about 3%) developed fever and marked leukopenia." | 3.65 | Acute leukopenia as an allergic reaction to silver sulfadiazine in burn patients. ( Chan, CK; Jarrett, F; Moylan, JA, 1976) |
| " While not preventing this destruction of heat-injured epithelium by Travase, simultaneous use of topical silver sulfadiazine cream did reduce the weight loss and purulence associated with Travase therapy of burns." | 3.65 | The effect of Travase on heat-injured skin. ( Zawacki, BE, 1975) |
| "Nitrofurazone (N), povidone-iodine (P), and silver sulfadiazine (S) were compared in the emergency department outpatient treatment of 84 patients suffering second degree burns over less than 15% (adults) or 5% (children) of their total body surface area." | 3.65 | Treatment of second degree burns: nitrofurazone, povidone-iodine, and silver sulfadiazine. ( Crenshaw, CA; Glanges, E; Webber, CE, 1977) |
| "Clinical wound infection with Staph, aureus developed in one Silvazine treated patient and five Flamazine treated patients (P = 0." | 2.65 | Prospective comparison of silver sulfadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent (Silvazine) and silver sulfadiazine 1 per cent (Flamazine) as prophylaxis against burn wound infection. ( Boyle, JC; Inman, RJ; Roberts, FJ; Shaw, K; Snelling, CF, 1984) |
| "People with burns are particularly vulnerable to infections; over 75% of all burn deaths (after initial resuscitation) result from infection." | 2.55 | Antiseptics for burns. ( Christie, J; Dumville, JC; Edwards, J; Hassan, IA; Hudson, T; Jefferies, JM; Liu, Z; Mohapatra, DP; Norman, G; Westby, MJ, 2017) |
| "Zinc sulfadiazine is a new compound which is effective in vitro and in vivo against Pseudomonas aeruginosa infections in burned mice and rats." | 1.26 | Zinc sulfadiazine for topical therapy of pseudomonas infection in burns. ( Fox, CL; Modak, SM; Stanford, JW, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 154 (83.70) | 18.7374 |
| 1990's | 18 (9.78) | 18.2507 |
| 2000's | 6 (3.26) | 29.6817 |
| 2010's | 3 (1.63) | 24.3611 |
| 2020's | 3 (1.63) | 2.80 |
| Authors | Studies |
|---|---|
| Dhar, LK | 1 |
| Jahan, I | 1 |
| Talukder, A | 1 |
| Hossain, MA | 1 |
| Kaiser, A | 1 |
| Razia, S | 1 |
| Sarker, B | 1 |
| Anam, S | 1 |
| Satter, T | 1 |
| Ali, A | 1 |
| Bhuiyan, MH | 1 |
| Abdullahzadeh, M | 1 |
| Shafiee, S | 1 |
| Lelievre, B | 1 |
| Tellier, AC | 1 |
| Colonna, G | 1 |
| Cohen, B | 1 |
| Cazaubon, Y | 1 |
| Leccia, F | 1 |
| Darrouzain, F | 1 |
| Deguigne, M | 1 |
| Norman, G | 1 |
| Christie, J | 1 |
| Liu, Z | 1 |
| Westby, MJ | 1 |
| Jefferies, JM | 1 |
| Hudson, T | 1 |
| Edwards, J | 1 |
| Mohapatra, DP | 1 |
| Hassan, IA | 1 |
| Dumville, JC | 1 |
| Kurowska, A | 1 |
| Ghate, V | 1 |
| Kodoth, A | 1 |
| Shah, A | 2 |
| Vishalakshi, B | 1 |
| Prakash, B | 1 |
| Lewis, SA | 1 |
| Yenilmez, E | 1 |
| Başaran, E | 1 |
| Arslan, R | 1 |
| Berkman, MS | 1 |
| Güven, UM | 1 |
| Bayçu, C | 1 |
| Yazan, Y | 1 |
| MUIRHEAD, EE | 1 |
| HILL, JM | 1 |
| Wasiak, J | 1 |
| Cleland, H | 1 |
| Luo, XS | 1 |
| Cen, Y | 1 |
| Zhao, JH | 1 |
| Harley, OJ | 1 |
| Dziewulski, P | 1 |
| Suhr, M | 1 |
| Kreusch, T | 1 |
| Tsai, TC | 1 |
| Peng, SK | 1 |
| Shih, YR | 1 |
| Luk, HN | 1 |
| Engrav, LH | 2 |
| Heimbach, DM | 2 |
| Reus, JL | 1 |
| Harnar, TJ | 1 |
| Marvin, JA | 2 |
| Hoffmann, S | 2 |
| Inman, RJ | 1 |
| Snelling, CF | 2 |
| Roberts, FJ | 1 |
| Shaw, K | 1 |
| Boyle, JC | 1 |
| McManus, AT | 1 |
| Denton, CL | 1 |
| Mason, AD | 2 |
| Youssef, S | 1 |
| Pochon, JP | 1 |
| Modak, SM | 2 |
| Fox, CL | 14 |
| Yano, M | 1 |
| Watanabe, C | 1 |
| Mashiko, K | 1 |
| Kurokawa, A | 1 |
| Yamamoto, Y | 1 |
| Henmi, H | 1 |
| Otsuka, T | 1 |
| Hermans, RP | 1 |
| Zhang, ML | 1 |
| Modak, S | 4 |
| Stanford, J | 2 |
| Friedlaender, J | 1 |
| Fox, P | 1 |
| Lockhart, SP | 1 |
| Rushworth, A | 1 |
| Azmy, AA | 1 |
| Raine, PA | 1 |
| Robb, EC | 2 |
| Fitz, DG | 1 |
| Nathan, P | 3 |
| Hirakawa, K | 1 |
| Curreri, PW | 3 |
| Desai, MH | 1 |
| Bartlett, RH | 1 |
| Parshley, P | 1 |
| Trunkey, D | 1 |
| Bowser, BH | 1 |
| Caldwell, FT | 1 |
| Cone, JB | 1 |
| Eisenach, KD | 1 |
| Thompson, CH | 1 |
| Akahane, T | 1 |
| Tsukada, S | 1 |
| Sano, S | 1 |
| Fujimori, R | 1 |
| Takashima, M | 1 |
| Itokawa, Y | 1 |
| Caffee, HH | 1 |
| Bingham, HG | 1 |
| Rode, H | 1 |
| de Wet, PM | 1 |
| Davies, MR | 1 |
| Cywes, S | 1 |
| Clarke, SD | 1 |
| Gallur, L | 1 |
| Threlfall, GN | 1 |
| Salisbury, RE | 1 |
| Bevin, AG | 1 |
| Steinkraus, GE | 1 |
| Enterline, DS | 1 |
| Harrison, PV | 1 |
| Munster, AM | 3 |
| Helvig, E | 1 |
| Rowland, S | 1 |
| Lee, AR | 1 |
| Huang, WH | 1 |
| Cui, XL | 1 |
| Guo, ZR | 2 |
| Sheng, ZY | 1 |
| Kowal-Vern, A | 1 |
| Walenga, JM | 1 |
| Hoppensteadt, D | 1 |
| Sharp-Pucci, M | 1 |
| Gamelli, RL | 1 |
| Hollinger, MA | 1 |
| Guo, Z | 1 |
| Gao, W | 1 |
| He, L | 1 |
| Donati, L | 1 |
| Periti, P | 1 |
| Andreassi, A | 1 |
| Dioguardi, D | 1 |
| Gliori, A | 1 |
| Landi, G | 1 |
| Magliacani, G | 1 |
| Marinelli, LF | 1 |
| Masellis, M | 1 |
| Barachini, P | 1 |
| Micali, G | 1 |
| Papadia, F | 1 |
| Rapisarda, V | 1 |
| Savoia, A | 1 |
| Bersieri, M | 1 |
| D'Arpa, N | 1 |
| De Bellis, A | 1 |
| Di Lonardo, A | 1 |
| Faggiano, G | 1 |
| Gianfaldoni, R | 1 |
| Magliano, E | 1 |
| Marasco, L | 1 |
| Novelli, A | 1 |
| Ranno, R | 1 |
| Zermani, R | 1 |
| Bugmann, P | 1 |
| Taylor, S | 1 |
| Gyger, D | 1 |
| Lironi, A | 1 |
| Genin, B | 1 |
| Vunda, A | 1 |
| La Scala, G | 1 |
| Birraux, J | 1 |
| Le Coultre, C | 1 |
| Barret, JP | 1 |
| Gomez, P | 1 |
| Solano, I | 1 |
| Gonzalez-Dorrego, M | 1 |
| Crisol, FJ | 1 |
| Ran, X | 1 |
| Yan, Y | 1 |
| Lin, Y | 1 |
| Cruz, E | 1 |
| Singer, AJ | 1 |
| Mohammad, M | 1 |
| Tortora, G | 1 |
| Thode, HC | 1 |
| McClain, SA | 1 |
| Ronald, AR | 1 |
| Waters, WR | 1 |
| Yaworski, DS | 1 |
| Drulak, K | 1 |
| Sunderland, M | 1 |
| Bridges, K | 2 |
| Lowbury, EJ | 4 |
| Kiker, RG | 1 |
| Carvajal, HF | 1 |
| Mlcak, RP | 1 |
| Larson, DL | 2 |
| Jarrett, F | 2 |
| Maki, DG | 1 |
| Chan, CK | 2 |
| Fraser, GL | 1 |
| Beaulieu, JT | 1 |
| Helvig, EI | 1 |
| Su, CT | 1 |
| Oppel, W | 1 |
| Harrison, HN | 1 |
| Mayhall, CG | 2 |
| Lamb, VA | 2 |
| Gayle, WE | 2 |
| Haynes, BW | 4 |
| Micheels, J | 1 |
| Moray, V | 1 |
| Castermans, A | 1 |
| Stanford, JW | 3 |
| Fox, PL | 1 |
| Pegg, SP | 1 |
| Ramsay, K | 1 |
| Meldrum, L | 1 |
| Laundy, M | 1 |
| Valente, P | 1 |
| Axelrod, JL | 1 |
| Fisher, JH | 1 |
| Apollo, E | 1 |
| Ugland, OM | 1 |
| Denny, AD | 1 |
| Twomey, JA | 1 |
| Hitchcock, CR | 1 |
| Larkin, JM | 1 |
| Moylan, JA | 2 |
| Drake, DJ | 1 |
| Froese, EH | 1 |
| Clarke, AM | 4 |
| Catania, PN | 1 |
| King, JC | 1 |
| Babb, JR | 1 |
| Jackson, DM | 3 |
| Monafo, WW | 1 |
| Ayvazian, VH | 1 |
| Skinner, AM | 1 |
| Condict, C | 1 |
| Webber, CE | 1 |
| Glanges, E | 1 |
| Crenshaw, CA | 1 |
| Charoonsmith, T | 1 |
| Satienchoke, M | 1 |
| Tittiranonda, T | 1 |
| Tiewtranonda, P | 1 |
| Lunan, HN | 1 |
| Warden, GD | 1 |
| Pruitt, BA | 3 |
| Zawacki, BE | 1 |
| Hart, RJ | 1 |
| Lee, JO | 1 |
| Boyles, DJ | 1 |
| Batey, NR | 1 |
| Henderson, RN | 1 |
| Stefanides, MM | 1 |
| Copeland, CE | 1 |
| Kominos, SD | 1 |
| Yee, RB | 1 |
| Masterton, JP | 1 |
| Bocchiotti, G | 1 |
| Robotti, E | 1 |
| Bentivegna, PE | 1 |
| Wyatt, D | 1 |
| McGowan, DN | 1 |
| Najarian, MP | 1 |
| Aoyama, H | 1 |
| Yokoo, K | 1 |
| Fujii, K | 1 |
| Li, TZ | 2 |
| Gerding, RL | 2 |
| Emerman, CL | 1 |
| Effron, D | 1 |
| Lukens, T | 1 |
| Imbembo, AL | 2 |
| Fratianne, RB | 2 |
| Kudlácková, M | 1 |
| Sawhney, CP | 1 |
| Sharma, RK | 1 |
| Rao, KR | 1 |
| Kaushish, R | 1 |
| Kartal, A | 1 |
| Tatkan, Y | 1 |
| Belviranli, M | 1 |
| Sahin, M | 1 |
| Duman, S | 1 |
| Karahan, O | 1 |
| Gurbilek, M | 1 |
| Temur, S | 1 |
| Deitch, EA | 1 |
| Sittig, K | 1 |
| Heimbach, D | 1 |
| Jordan, M | 1 |
| Cruse, W | 1 |
| Kahn, A | 1 |
| Achauer, B | 1 |
| Finley, R | 1 |
| Matsuda, T | 1 |
| Salisbury, R | 1 |
| Maxwell, GP | 1 |
| Tornambe, R | 1 |
| Cruse, CW | 1 |
| Daniels, S | 1 |
| Stern, HS | 1 |
| Savadian, ESh | 1 |
| Koo, DS | 1 |
| Zhen, S | 1 |
| Zhen, ZD | 1 |
| Shi, XW | 1 |
| Xiang, SJ | 1 |
| Richey, KJ | 1 |
| Walkinshaw, MD | 1 |
| Gottlieb, JR | 1 |
| Wassermann, D | 1 |
| Schlotterer, M | 1 |
| Lebreton, F | 1 |
| Levy, J | 1 |
| Guelfi, MC | 1 |
| Sawada, Y | 1 |
| Lai, CS | 1 |
| Miskell, P | 1 |
| Gonce, SJ | 1 |
| Alexander, JW | 3 |
| Babcock, GF | 1 |
| Ge, SD | 2 |
| Lorenz, C | 1 |
| Specht, U | 1 |
| Beyer, W | 1 |
| Ströhmann, F | 1 |
| Garbe, S | 1 |
| Mau, H | 1 |
| Love, D | 1 |
| Kubey, W | 1 |
| Holmes, CJ | 1 |
| Gbaanador, GB | 1 |
| Policastro, AJ | 1 |
| Durfee, D | 1 |
| Bleicher, JN | 1 |
| Choban, PS | 1 |
| Marshall, WJ | 1 |
| Wilson, P | 1 |
| George, R | 1 |
| Raine, P | 1 |
| Boosalis, MG | 1 |
| McCall, JT | 1 |
| Ahrenholz, DH | 1 |
| Solem, LD | 1 |
| McClain, CJ | 1 |
| Jia, XM | 1 |
| Stair, TO | 1 |
| D'Orta, J | 1 |
| Altieri, MF | 1 |
| Lippe, MS | 1 |
| Fligner, CL | 1 |
| Jack, R | 1 |
| Twiggs, GA | 1 |
| Raisys, VA | 1 |
| Wang, XW | 1 |
| Wang, NZ | 1 |
| Zhang, OZ | 1 |
| Zapata-Sirvent, RL | 1 |
| Davies, JW | 2 |
| Hull, D | 1 |
| Grindlinger, GA | 1 |
| Hirsch, EF | 1 |
| Petrone, S | 1 |
| Burke, J | 1 |
| Boeckx, W | 1 |
| Focquet, M | 1 |
| Cornelissen, M | 1 |
| Nuttin, B | 1 |
| Kulick, MI | 1 |
| Wong, R | 1 |
| Okarma, TB | 1 |
| Falces, E | 1 |
| Berkowitz, RL | 1 |
| Kaufman, T | 1 |
| Levin, M | 1 |
| Hebda, PA | 1 |
| Eichenlaub, EH | 1 |
| Korol, B | 1 |
| Solomon, J | 2 |
| Keogh, J | 2 |
| Nixon, M | 2 |
| Burchett, J | 2 |
| Lilly, HA | 1 |
| Cason, JS | 2 |
| Bull, JP | 1 |
| Ford, PM | 1 |
| Loebl, EC | 1 |
| Baxter, CR | 1 |
| Popp, MB | 1 |
| Law, EJ | 1 |
| MacMillian, BG | 1 |
| Hummel, RP | 2 |
| Kautz, PD | 1 |
| MacMillan, BG | 4 |
| Altemeier, WA | 2 |
| Robson, MC | 3 |
| Schaerf, RH | 1 |
| Krizek, TJ | 6 |
| Levin, JM | 1 |
| Bornstein, LA | 1 |
| Groskin, MG | 1 |
| McDougall, IA | 2 |
| Rosenthal, SM | 3 |
| Zimmermann, WE | 1 |
| Oehlert, W | 1 |
| Dietrich, FE | 1 |
| Garrison, AF | 1 |
| Jelenko, C | 1 |
| Ballin, JC | 1 |
| Donald, M | 1 |
| Dickinson, SJ | 1 |
| Ryan, RF | 1 |
| Flagg, SV | 2 |
| Wolfort, FG | 1 |
| Jabaley, ME | 1 |
| Polk, HC | 1 |
| King, N | 1 |
| Weiner, LJ | 1 |
| Lloyd, JR | 1 |
| Levenson, SM | 1 |
| Kan, D | 1 |
| Gruber, C | 1 |
| Crowley, LV | 1 |
| Lent, R | 1 |
| Watford, A | 1 |
| Seifter, E | 1 |
| Moncrief, JA | 1 |
| Boswick, JA | 1 |
| Cossman, DV | 2 |
| Shuck, JM | 1 |
| Reid, WH | 1 |
| Keogh, EJ | 1 |
| Dimick, AR | 1 |
| Evans, AJ | 1 |
| Buckley, CJ | 1 |
| Chambers, CE | 1 |
| Kemmerer, WT | 1 |
| Rawlings, CA | 1 |
| Casey, HW | 1 |
| Hall, CW | 1 |
| Markley, K | 1 |
| Sampath, AC | 1 |
| Fisher, MW | 1 |
| Headley, BJ | 1 |
| Ollstein, RN | 1 |
| Symonds, FC | 1 |
| Crikelair, GF | 1 |
| Pelle, L | 1 |
| Ricketts, CR | 1 |
| Davis, B | 1 |
| Abston, S | 1 |
| Capen, DA | 1 |
| Clement, RL | 1 |
| Grossman, AR | 1 |
| Converse, JM | 1 |
| Rapaport, FT | 1 |
| Dressler, DP | 1 |
| Skornik, WA | 1 |
| Velasco, JE | 1 |
| Africk, JA | 1 |
| Stanford, W | 2 |
| Rappole, BW | 2 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Tranexamic Acid (TXA) on Blood Loss and Transfusion Rates in Burn Wound Surgery - A Randomized, Double-Blinded Placebo-Controlled Trial[NCT02753816] | 25 participants (Actual) | Interventional | 2016-04-30 | Terminated (stopped due to Study enrollment and goals unable to be reached.) | |||
| Cost-effectiveness of Laser Doppler Imaging in Burn Care in the Netherlands[NCT01489540] | 200 participants (Anticipated) | Interventional | 2011-12-31 | Completed | |||
| The Burn Glove Trial-A Randomized Controlled Trial of Dressings for Partial Thickness Hand Burns[NCT02318056] | 0 participants (Actual) | Interventional | 2015-12-31 | Withdrawn (stopped due to Due to reorganization.) | |||
| A Comparison of Mepitel Ag vs Antibiotic Ointment When Used With the Soft Cast Technique for the Treatment of Pediatric Hand and Foot Burns, a Prospective Study[NCT02681757] | 96 participants (Actual) | Interventional | 2016-09-30 | Completed | |||
| Comparative Prospective Study of Mepilex Ag vs. Xeroform in Pediatric Patients That Sustain Partial Thickness Burn Injury[NCT04149808] | 0 participants (Actual) | Interventional | 2019-11-01 | Withdrawn (stopped due to The study was never conducted and no parcipants were ever enrolled and study never initiated.) | |||
| Porcine Xenograft Versus Second Intention Healing: a Randomized, Evaluator-blinded Clinical Trial[NCT03931746] | 14 participants (Actual) | Interventional | 2019-06-11 | Terminated (stopped due to Company discontinued production of the Porcine Xenograft) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
To determine the impact of perioperative administration of Tranexamic Acid on transfusion rates in major burn surgeries. (NCT02753816)
Timeframe: First burn surgery to hospital discharge
| Intervention | Patients with 1 or more transfusions (Number) |
|---|---|
| Tranexamic Acid | 2 |
| Placebo | 3 |
To determine the impact of Tranexamic Acid on total hospital length of stay by comparing the hospital admission date and the hospital discharge date. This determination will take into account current burn size and location, procedures performed and their effect on wound healing and skin graft survival. (NCT02753816)
Timeframe: Hospital admission to hospital discharge
| Intervention | Days (Median) |
|---|---|
| Tranexamic Acid | 23 |
| Placebo | 9 |
To determine the impact of perioperative administration of Tranexamic Acid on blood loss in major burn surgeries. (NCT02753816)
Timeframe: Intraoperative, average 122 minutes
| Intervention | mL (Median) |
|---|---|
| Tranexamic Acid | 100 |
| Placebo | 325 |
Burn will be evaluated every 3-7 days from date of randomization for up to 21 days (End of Study) after application of Mepitel Ag or triple antibiotic ointment impregnated Adaptic gauze to determine if the burn healed or not. (NCT02681757)
Timeframe: Up to 21 days
| Intervention | Burns (Count of Units) |
|---|---|
| Control- Triple Antibiotic Ointment | 43 |
| Variable- Mepitel Ag | 51 |
Subject will be evaluated every 3-7 days from date of randomization for up to 21 days (End of Study) for clinically observed evidence of yeast infection from visible wound inspection at time of dressing change, i.e.: foul yeast odor, red erythematous rash. (NCT02681757)
Timeframe: Up to 21 days
| Intervention | burns (Number) |
|---|---|
| Control- Triple Antibiotic Ointment | 5 |
| Variable- Mepitel Ag | 6 |
"Healing time will be measured in weeks based on patient's responses to question 1 of the weekly follow-up questionnaire (Is the wound completely healed (i.e., wound is completely closed with no open areas)?). For example, a patient who first replies Yes to this question on the third weekly follow-up questionnaire will be assigned a healing time of 3 weeks. A more objective measure of healing time would not be feasible given our resources and patient schedule." (NCT03931746)
Timeframe: Up to 38 weeks
| Intervention | weeks (Median) |
|---|---|
| Porcine Xenograft Placement | 14.0 |
| No Porcine Xenograft | 13.0 |
Patient's charts will be reviewed at the completion of their 3-month office visit follow-up in order to analyze if they visited the dermatologist between the date of surgery and 3-month office visit and if infection was diagnosed. (NCT03931746)
Timeframe: 3 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Porcine Xenograft Placement | 2 |
| No Porcine Xenograft | 2 |
"This outcome describes the number of patients in each treatment group receiving treatment with silver nitrate sticks as a rescue medication due to lack of complete wound healing at the 3-month (+- 1 month) visit following surgery." (NCT03931746)
Timeframe: 3 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Porcine Xenograft Placement | 2 |
| No Porcine Xenograft | 1 |
Patients' pain scores will be measured based on their response to question 2 of the weekly follow-up questionnaire. Patients will be asked to rate their current pain level at the operative site on a scale from 1 (no pain) to 10 (worst imaginable pain). (NCT03931746)
Timeframe: 3 months
| Intervention | weeks (Median) |
|---|---|
| Porcine Xenograft Placement | 2.0 |
| No Porcine Xenograft | 1.0 |
Patients' pain scores will be measured based on their response to question 2 of the weekly follow-up questionnaire. Patients will be asked to rate their current pain level at the operative site on a scale from 1 (no pain) to 10 (worst imaginable pain). (NCT03931746)
Timeframe: 1 week
| Intervention | score on a scale (Median) |
|---|---|
| Porcine Xenograft Placement | 1.0 |
| No Porcine Xenograft | 1.5 |
The proportion of patients with a pain score greater than or equal to 6 at the operative site will be assessed at one week following surgery. This will be based on the patient's response to the weekly follow-up questionnaire, with scores ranging from 1 (no pain) to 10 (worst imaginable pain). (NCT03931746)
Timeframe: 1 week
| Intervention | Participants (Count of Participants) |
|---|---|
| Porcine Xenograft Placement | 1 |
| No Porcine Xenograft | 1 |
"The primary outcome will be the total score of the POSAS observer scale, assessed at the 3-month (+/- 1 month) follow-up visit by two blinded evaluators who will not be involved in the placement of the porcine xenograft. For each patient, scores from the two blinded investigators will be combined by calculating the mean. The POSAS (Patient and Observer Scar Assessment Scale) is a validated assessment tool used for the assessment of all types of scars by professionals and patients. The observer scale is comprised of 6 items (vascularity, pigmentation, thickness, relief, pliability, and surface area) scored on a scale from 1(like normal skin) to 10 (worst scar imaginable). The total score is calculated as the sum of the six items (range, 6-60)." (NCT03931746)
Timeframe: Between 2.70 to 8.75 months
| Intervention | score on a scale (Median) |
|---|---|
| Porcine Xenograft Placement | 17.0 |
| No Porcine Xenograft | 20.5 |
"Study participants will complete the POSAS patient scale at the 3-month follow-up visit. The POSAS (Patient and Observer Scar Assessment Scale) patient scale consists of 6 items assessing patients' subjective opinion of scar quality in terms of pain, itching, color, pliability, thickness, and relief. Each item is scored from 1 (normal pigmentation, no itching, etc.) to 10 (worst imaginable scar or sensation). The total score of the POSAS patient scale is calculated as the sum of the six items (range, 6-60)." (NCT03931746)
Timeframe: 3 months
| Intervention | score on a scale (Median) |
|---|---|
| Porcine Xenograft Placement | 15.0 |
| No Porcine Xenograft | 18.0 |
During each of the weekly follow-up questionnaires and during the 3-month follow-up visit, patients will be asked if they have experienced any post-operative bleeding that led to a visit to the physician (yes/no) and if there was any intervention performed by the physician to stop the bleeding (yes/no). The number and percentage of patients who experienced bleeding at any time during the 3-month follow-up period will be reported. (NCT03931746)
Timeframe: 3 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Porcine Xenograft Placement | 0 |
| No Porcine Xenograft | 1 |
The initial postoperative defect size will be measured by the investigator prior to intervention in terms of length and width using a sterile ruler. Initial defect area will be calculated as length times width. Scar size will be measured in terms of length and width at the 3-month follow-up visit, and scar area will be calculated as length times width. The outcome will be calculated by dividing the scar area by the initial defect area. (NCT03931746)
Timeframe: 3 months
| Intervention | ratio (Median) |
|---|---|
| Porcine Xenograft Placement | 0.43 |
| No Porcine Xenograft | 0.35 |
14 reviews available for sulfadiazine and Burns
| Article | Year |
|---|---|
Antiseptics for burns.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Apitherapy; Bacterial Infections; Bandag | 2017 |
Burns (minor thermal).
Topics: Bandages; Bandages, Hydrocolloid; Burns; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Incid | 2009 |
Burn injuries resulting from (accidental) airbag inflation.
Topics: Aged; Air Bags; Anti-Infective Agents, Local; Burns; Burns, Chemical; Chlorhexidine; Equipment Desig | 2004 |
Silver sulfadiazine: an antibacterial agent for topical use in burns. A review of the literature.
Topics: Administration, Topical; Animals; Bacterial Infections; Burns; Drug Resistance, Microbial; Humans; M | 1984 |
Toxicological aspects of topical silver pharmaceuticals.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Burns; Drug Combinations; Electrodes | 1996 |
[The use of a topical antibacterial agent (silver sulfadiazine) on soft-tissue wounds].
Topics: Acute Disease; Administration, Topical; Burns; Chronic Disease; Humans; Silver Sulfadiazine; Skin Di | 1990 |
Silver sulphadiazine and the healing of partial thickness burns: a prospective clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Bandages; Burns; Clinical Trials as Topic; Depression, Chemical; Fem | 1989 |
[Use of silver preparations in surgery and traumatology (review of foreign literature)].
Topics: Animals; Anti-Infective Agents, Local; Bacterial Infections; Burns; Europe; Humans; Mice; Osteomyeli | 1989 |
Burns in children.
Topics: Administration, Topical; Antifungal Agents; Bandages; Burns; Catheterization; Child; Child, Preschoo | 1974 |
Recent advances in the management of burns.
Topics: Bandages; Burns; Duodenal Obstruction; Duodenal Ulcer; Gentamicins; Humans; Methods; Ointments; Pare | 1971 |
Modern trends in care of the burn patient.
Topics: Anti-Bacterial Agents; Burns; Burns, Inhalation; Comprehensive Health Care; Debridement; Emotions; G | 1973 |
Topical antibacterial therapy of the burn wound.
Topics: Administration, Topical; Adolescent; Anti-Infective Agents, Local; Bacterial Infections; Biopsy; Blo | 1974 |
The management of fresh burns of the hand and deformities resulting from burn injuries.
Topics: Administration, Topical; Aged; Anti-Infective Agents, Local; Bacterial Infections; Bandages; Burns; | 1974 |
Burn therapy--a current appraisal.
Topics: Administration, Topical; Adolescent; Adult; Animals; Burns; Child; Child, Preschool; Duodenal Ulcer; | 1971 |
20 trials available for sulfadiazine and Burns
| Article | Year |
|---|---|
To compare the effect of sea buckthorn and silver sulfadiazine dressing on period of wound healing in patients with second-degree burns: A randomized triple-blind clinical trial.
Topics: Anti-Infective Agents, Local; Bandages; Burns; Hippophae; Humans; Silver Sulfadiazine; Sulfadiazine; | 2021 |
Early excision and grafting vs. nonoperative treatment of burns of indeterminant depth: a randomized prospective study.
Topics: Adolescent; Adult; Aged; Burns; Child; Child, Preschool; Cicatrix; Clinical Trials as Topic; Female; | 1983 |
Early excision and grafting vs. nonoperative treatment of burns of indeterminant depth: a randomized prospective study.
Topics: Adolescent; Adult; Aged; Burns; Child; Child, Preschool; Cicatrix; Clinical Trials as Topic; Female; | 1983 |
Early excision and grafting vs. nonoperative treatment of burns of indeterminant depth: a randomized prospective study.
Topics: Adolescent; Adult; Aged; Burns; Child; Child, Preschool; Cicatrix; Clinical Trials as Topic; Female; | 1983 |
Early excision and grafting vs. nonoperative treatment of burns of indeterminant depth: a randomized prospective study.
Topics: Adolescent; Adult; Aged; Burns; Child; Child, Preschool; Cicatrix; Clinical Trials as Topic; Female; | 1983 |
Prospective comparison of silver sulfadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent (Silvazine) and silver sulfadiazine 1 per cent (Flamazine) as prophylaxis against burn wound infection.
Topics: Adolescent; Adult; Bacteria; Burns; Child; Chlorhexidine; Clinical Trials as Topic; Drug Therapy, Co | 1984 |
Safety and efficacy of a new synthetic burn dressing: a multicenter study.
Topics: Acrylates; Administration, Topical; Adolescent; Adult; Body Surface Area; Burns; Child; Clinical Tri | 1980 |
A prospective analysis of silver sulfadiazine with and without cerium nitrate as a topical agent in the treatment of severely burned children.
Topics: Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Burns; Ceri | 1981 |
Leukopenia and silver sulfadiazine.
Topics: Adult; Burns; Cimetidine; Drug Interactions; Guanidines; Humans; Leukopenia; Peptic Ulcer; Prospecti | 1982 |
Cerium nitrate-silver sulfadiazine cream in the treatment of burns: a prospective evaluation.
Topics: Adult; Bacterial Infections; Burns; Cerium; Drug Combinations; Humans; Middle Aged; Nitrates; Ointme | 1980 |
Increased burn patient survival with once-a-day high dose teicoplanin and netilmicin. An Italian multicenter study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Body Surfa | 1998 |
A silicone-coated nylon dressing reduces healing time in burned paediatric patients in comparison with standard sulfadiazine treatment: a prospective randomized trial.
Topics: Adolescent; Anti-Infective Agents; Burns; Child; Child, Preschool; Coated Materials, Biocompatible; | 1998 |
A silicone-coated nylon dressing reduces healing time in burned paediatric patients in comparison with standard sulfadiazine treatment: a prospective randomized trial.
Topics: Adolescent; Anti-Infective Agents; Burns; Child; Child, Preschool; Coated Materials, Biocompatible; | 1998 |
A silicone-coated nylon dressing reduces healing time in burned paediatric patients in comparison with standard sulfadiazine treatment: a prospective randomized trial.
Topics: Adolescent; Anti-Infective Agents; Burns; Child; Child, Preschool; Coated Materials, Biocompatible; | 1998 |
A silicone-coated nylon dressing reduces healing time in burned paediatric patients in comparison with standard sulfadiazine treatment: a prospective randomized trial.
Topics: Adolescent; Anti-Infective Agents; Burns; Child; Child, Preschool; Coated Materials, Biocompatible; | 1998 |
A controlled study of the effects of silver sulfadiazine on white blood cell counts in burned children.
Topics: Adolescent; Burns; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Humans; I | 1977 |
Cerium nitrate-silver sulfadiazine cream in the treatment of burns: a prospective, randomized study.
Topics: Adult; Bacteria; Burns; Cerium; Drug Combinations; Female; Humans; Male; Microbial Sensitivity Tests | 1979 |
Topical chemoprophylaxis with silver sulphadiazine and silver nitrate chlorhexidine creams: emergence of sulphonamide-resistant Gram-negative bacilli.
Topics: Administration, Topical; Adolescent; Adult; Bacteria; Biguanides; Burns; Child; Child, Preschool; Ch | 1976 |
Comparison of a hydrocolloid dressing and silver sulfadiazine cream in the outpatient management of second-degree burns.
Topics: Adolescent; Adult; Ambulatory Care; Bandages; Bandages, Hydrocolloid; Burns; Child; Child, Preschool | 1990 |
Outpatient management of partial-thickness burns: Biobrane versus 1% silver sulfadiazine.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Biocompatible Materials; Burns; Child; Child, Preschool; C | 1990 |
Results of a multicenter outpatient burn study on the safety and efficacy of Dimac-SSD, a new delivery system for silver sulfadiazine.
Topics: Acrylates; Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; B | 1989 |
Minor burns: treatment using a new drug delivery system with silver sulfadiazine.
Topics: Acrylates; Adhesiveness; Burns; Child; Clinical Trials as Topic; Delayed-Action Preparations; Dimeth | 1989 |
Silver sulphadiazine and the healing of partial thickness burns: a prospective clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Bandages; Burns; Clinical Trials as Topic; Depression, Chemical; Fem | 1989 |
Biosynthetic skin substitute vs. 1% silver sulfadiazine for treatment of inpatient partial-thickness thermal burns.
Topics: Adolescent; Adult; Biocompatible Materials; Burns; Coated Materials, Biocompatible; Costs and Cost A | 1988 |
Polyurethane and silver sulfadiazene dressings in treatment of partial-thickness burns and abrasions.
Topics: Adolescent; Adult; Aged; Burns; Child; Child, Preschool; Humans; Infant; Middle Aged; Occlusive Dres | 1986 |
Alternative forms of local treatment for burns.
Topics: Acetates; Adolescent; Adult; Aged; Air; Body Temperature; Burns; Child; Child, Preschool; Enterobact | 1971 |
151 other studies available for sulfadiazine and Burns
| Article | Year |
|---|---|
A Comparative Study of Collagen Sheet versus 1% Silver Sulfadiazine Dressing in Superficial Partial Thickness Burns.
Topics: Adolescent; Adult; Anti-Infective Agents, Local; Bandages; Bangladesh; Burns; Child; Child, Preschoo | 2022 |
High silver concentrations in biological samples following different exposures: Two case reports.
Topics: Burns; Female; Humans; Metal Nanoparticles; Silver; Silver Sulfadiazine; Sulfadiazine | 2021 |
Non-Propellant Foams of Green Nano-Silver and Sulfadiazine: Development and In Vivo Evaluation for Burn Wounds.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Burns; Drug Compounding; Drug Therapy, Comb | 2019 |
Chitosan gel formulations containing egg yolk oil and epidermal growth factor for dermal burn treatment.
Topics: Administration, Cutaneous; Animals; Anti-Infective Agents; Burns; Chemistry, Pharmaceutical; Chitosa | 2015 |
Burn case; intrasternal administration of plasma; sulfadiazine complications.
Topics: Burns; Humans; Sulfadiazine | 1947 |
[Therapeutic effect of liposome on II degree burn wound].
Topics: Administration, Topical; Adolescent; Adult; Burns; Child; Female; Humans; Liposomes; Male; Middle Ag | 2000 |
Accidental burns caused by domestic infra-red muscle massaging device.
Topics: Adult; Anti-Infective Agents; Burns; Female; Humans; Infrared Rays; Massage; Radiation Injuries; Sul | 2003 |
Sulfadiazine-induced methemoglobinemia in a boy with thalassemia.
Topics: Anti-Infective Agents, Local; Antidotes; Burns; Child, Preschool; Debridement; Female; Humans; Methe | 2005 |
Mechanisms of in vitro sensitivity to sulfadiazine silver.
Topics: Animals; Burns; Chemical Phenomena; Chemistry; DNA, Bacterial; Drug Resistance, Microbial; Electroph | 1983 |
[Comparative in vitro tests of silver sulphadiazine and zinc sulfadiazine swabs on burn patients].
Topics: Bacteria; Burns; Child; Child, Preschool; Female; Humans; Infant; Klebsiella; Male; Pseudomonas aeru | 1983 |
Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents.
Topics: Administration, Topical; Animals; Burns; Drug Resistance, Microbial; Female; In Vitro Techniques; Mi | 1981 |
[A clinical study on 164 patients with extensive burn--with special reference to improved survival factors].
Topics: Adult; Age Factors; Burns; Fluid Therapy; Humans; Prognosis; Sulfadiazine | 1984 |
Topical treatment of serious infections with special reference to the use of a mixture of silver sulphadiazine and cerium nitrate: two clinical studies.
Topics: Anti-Infective Agents, Local; Burns; Cerium; Drug Therapy, Combination; Humans; Prognosis; Silver Su | 1984 |
[Silver sulfadiazine (Flamazine). An antibacterial agent in the local prevention and therapy of burn wound infections].
Topics: Administration, Topical; Bacterial Infections; Burns; Humans; Silver Sulfadiazine; Sulfadiazine | 1984 |
[Invasive systemic infection in patients with extensive burns--analysis of 134 cases].
Topics: Anti-Bacterial Agents; Bacterial Infections; Burns; Humans; Sulfadiazine; Wound Infection | 1984 |
Control of burn wound infections by pefloxacin and its silver derivative.
Topics: Administration, Topical; Animals; Body Weight; Burns; Female; Mice; Nalidixic Acid; Pefloxacin; Pseu | 1984 |
Topical silver sulphadiazine: side effects and urinary excretion.
Topics: Administration, Topical; Burns; Child; Child, Preschool; Erythema Multiforme; Female; Humans; Infant | 1983 |
Delivery of the topical antimicrobial agents silver sulfadiazine, gentamicin and nystatin to infected burn wounds in rats from preloaded synthetic dressings.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bandages; Burns; Candida albicans; Delayed-Ac | 1980 |
Topical therapy and the development of silver sulfadiazine.
Topics: Administration, Topical; Adult; Aged; Animals; Burns; DNA, Bacterial; Female; Humans; Kinetics; Male | 1983 |
[Determination of silver and cerium in the liver and the kidney from a severely burned infant treated with silver sulfadiazine and cerium nitrate].
Topics: Anti-Infective Agents, Local; Burns; Cerium; Humans; Infant; Kidney; Liver; Male; Neutron Activation | 1983 |
Electron-microscopic observation on silver deposition in burn wounds treated with silver sulphadiazine cream.
Topics: Administration, Topical; Adolescent; Adult; Burns; Child; Child, Preschool; Female; Humans; Infant; | 1982 |
Absorption, excretion and tissue distribution of silver sulphadiazine.
Topics: Administration, Topical; Animals; Burns; Leukopenia; Male; Mice; Rats; Rats, Inbred Strains; Silver | 1982 |
An experimental evaluation of the germicidal efficacy of three topical antimicrobial agents in burns.
Topics: Administration, Topical; Animals; Burns; Disease Models, Animal; Mafenide; Male; Povidone; Povidone- | 1981 |
Control of experimental burn wound infections: comparative delivery of the antimicrobial agent (silver sulfadiazine) either from a cream base or from a solid synthetic dressing.
Topics: Animals; Burns; Dermatologic Agents; Microbial Sensitivity Tests; Occlusive Dressings; Ointments; Ra | 1981 |
Febrile reaction to silver sulphadiazine cream.
Topics: Burns; Child; Fever; Humans; Ointments; Silver Sulfadiazine; Sulfadiazine | 1981 |
Burn wound sepsis: effect of delayed treatment with topical chemotherapy on survival.
Topics: Administration, Topical; Animals; Burns; Cerium; Disease Models, Animal; Mafenide; Pseudomonas Infec | 1980 |
Burn management and dermatology.
Topics: Bacterial Infections; Burns; Humans; Silver Sulfadiazine; Skin Diseases; Sulfadiazine | 1980 |
Zinc sulphadiazines: novel topical antimicrobial agents for burns.
Topics: Animals; Bacteria; Burns; Chemical Phenomena; Chemistry, Physical; Crystallography, X-Ray; Male; Mic | 1995 |
[An efficacious topical agent--SD-Ag-azone cream].
Topics: Adult; Anti-Infective Agents, Local; Azepines; Burns; Drug Combinations; Female; Humans; Male; Silve | 1994 |
Interleukin-2 and interleukin-6 in relation to burn wound size in the acute phase of thermal injury.
Topics: Acute Disease; Adult; Age Factors; Aged; Blast Injuries; Burns; Burns, Chemical; Cytokines; Electric | 1994 |
[Comparison of therapeutic value of various topical agents in Pseudomonas aeruginosa infection. An experimental study].
Topics: Administration, Topical; Animals; Azepines; Burns; Drugs, Chinese Herbal; Female; Male; Pseudomonas | 1993 |
[The effect of different topical agents on pseudomonas infection of burn wound].
Topics: Animals; Anti-Infective Agents, Local; Azepines; Burns; Drug Combinations; Female; Male; Pseudomonas | 1995 |
Epidemiology and mortality of adult burns in Catalonia.
Topics: Abbreviated Injury Scale; Adult; Age Factors; Anti-Infective Agents, Local; Body Surface Area; Burns | 1999 |
[Effects of locally used SD zinc, SD silver and skin transplantation on the combined radiation-burn injury in the rat].
Topics: Administration, Topical; Animals; Burns; Cobalt Radioisotopes; Female; Radiation Injuries, Experimen | 1997 |
Ref.: BURNS 24 (1998) 609-612 - "a silicon-coated nylon dressing reduces healing time in burned paediatric patients in comparison with standard sulfadiazine treatment: a prospective randomised trial-Ph. Bugmann et cols".
Topics: Anti-Infective Agents; Burns; Child; Coated Materials, Biocompatible; Humans; Nylons; Occlusive Dres | 1999 |
Octylcyanoacrylate for the treatment of contaminated partial-thickness burns in swine: a randomized controlled experiment.
Topics: Animals; Anti-Bacterial Agents; Bandages; Burns; Cyanoacrylates; Debridement; Female; Sulfadiazine; | 2000 |
Comparison of silver sulfadiazine and gentamicin for topical prophylaxis against burn wound sepsis.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Burns; Candida; Child; Drug Resistance, Micro | 1978 |
Drug resistance in relation to use of silver sulphadiazine cream in a burns unit.
Topics: Acinetobacter; Anti-Bacterial Agents; Burns; Drug Resistance, Microbial; Enterobacteriaceae; Escheri | 1977 |
Management of septic thrombosis of the inferior vena cava caused by Candida.
Topics: Adult; Amphotericin B; Burns; Candidiasis; Femoral Vein; Humans; Male; Parenteral Nutrition; Sulfadi | 1978 |
Leukopenia secondary to sulfadiazine silver.
Topics: Adult; Burns; Humans; Leukopenia; Male; Silver Sulfadiazine; Sulfadiazine | 1979 |
Pharmacology of sulfadiazine silver. Its attachment to burned human and rat skin and studies of gastrointestinal absorption and extension.
Topics: Animals; Burns; Humans; Intestinal Absorption; Mafenide; Rats; Silver Sulfadiazine; Skin; Sulfadiazi | 1979 |
Enterobacter cloacae septicemia in a burn center: epidemiology and control of an outbreak.
Topics: Adolescent; Adult; Aged; Burns; Child; Child, Preschool; Disease Outbreaks; Enterobacter; Enterobact | 1979 |
A ten-year retrospective study of sepsis in severely burned patients treated with or without silver sulfadiazinate.
Topics: Burns; Drug Evaluation; Humans; Retrospective Studies; Sepsis; Silver Sulfadiazine; Sulfadiazine | 1979 |
Metal sulfonamides as antibacterial agents in topical therapy.
Topics: Administration, Topical; Animals; Bacterial Infections; Burns; Drug Evaluation, Preclinical; Humans; | 1979 |
Clinical comparison of maphenide and silver sulphadiazine.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Burns; Child; Drug Evaluation; | 1979 |
Acute leukopenia associated with silver sulfadiazine therapy.
Topics: Acute Disease; Burns; Humans; Leukopenia; Male; Middle Aged; Silver Sulfadiazine; Sulfadiazine | 1978 |
Treatment of second degree burns.
Topics: Burns; Humans; Sulfadiazine | 1978 |
Resistant Enterobacter cloacae in a burn center: the ineffectiveness of silver sulfadiazine.
Topics: Animals; Burns; Cross Infection; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infect | 1978 |
[Silver sulfadiazine in treatment of burns].
Topics: Burns; Humans; Silver Sulfadiazine; Sulfadiazine | 1978 |
A preliminary report on the spray application of topical silver sulfadiazine to burn wounds.
Topics: Administration, Topical; Aerosols; Burns; Humans; Silver Sulfadiazine; Sulfadiazine | 1978 |
The role of prophylactic antibiotics in burn care.
Topics: Administration, Topical; Anti-Bacterial Agents; Bacteria; Burns; Humans; Penicillins; Sepsis; Skin T | 1976 |
The preparation and invivo use of silver sulphadiazine cream for treatment of burns infected with Pseudomonas aeruginosa.
Topics: Burns; Humans; Ointments; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Sulfadiazine; Woun | 1975 |
Topical use of silver sulphadiazine and chlorhexidine in the prevention of infection in thermal injuries.
Topics: Administration, Topical; Anti-Infective Agents, Local; Bacteria; Biguanides; Burns; Child; Chlorhexi | 1975 |
Inhibition of supraeschar and subeschar Pseudomonas infection by silver sulfadiazine dry foam.
Topics: Animals; Burns; Guinea Pigs; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Sulfadiaz | 1975 |
Zinc sulfadiazine for topical therapy of pseudomonas infection in burns.
Topics: Administration, Topical; Animals; Blood Proteins; Burns; DNA; Eating; Lethal Dose 50; Mice; Pseudomo | 1976 |
Pharmacology and clinical use of silver sulfadiazine and related topical antimicrobial agents.
Topics: Burns; Humans; Ointments; Silver Sulfadiazine; Sulfadiazine; Wound Infection | 1977 |
Topical chemotherapy for burns using cerium salts and silver sulfadiazine.
Topics: Administration, Topical; Animals; Bacterial Infections; Burns; Cerium; Humans; Mice; Rats; Salts; Si | 1977 |
Treatment of second degree burns: nitrofurazone, povidone-iodine, and silver sulfadiazine.
Topics: Burns; Drug Evaluation; Humans; Nitrofurazone; Povidone; Povidone-Iodine; Silver Sulfadiazine; Sulfa | 1977 |
Silver sulfadiazine in the treatment of burns.
Topics: Administration, Topical; Burns; Humans; Silver; Sulfadiazine | 1976 |
Topical treatment of the burn patient.
Topics: Administration, Topical; Allantoin; Anti-Bacterial Agents; Antibodies, Anti-Idiotypic; Burns; Enzyme | 1975 |
Silver sulfadiazine for control of burn wound infections.
Topics: Adult; Aged; Bandages; Burns; Child; Humans; Middle Aged; Ointments; Silver; Skin Transplantation; S | 1975 |
Suppression of leukocyte chemotaxis in vitro by chemotherapeutic agents used in the management of thermal injuries.
Topics: Administration, Topical; Burns; Chemotaxis; Cytological Techniques; Hot Temperature; Humans; In Vitr | 1975 |
The effect of Travase on heat-injured skin.
Topics: Administration, Topical; Animals; Body Weight; Burns; Debridement; Disease Models, Animal; Drug Eval | 1975 |
The Summerland Disaster.
Topics: Affective Symptoms; Asphyxia; Blood Donors; Burns; Carbon Monoxide Poisoning; Death; Disasters; Emer | 1975 |
Letter:Silver sulfadiazine.
Topics: Burns; Humans; Mafenide; Placebos; Silver; Sulfadiazine | 1975 |
Letter: Silver sulfadiazine adverse effects.
Topics: Burns; Humans; Silver; Sulfadiazine | 1975 |
In vitro penetration of topical antiseptics through eschar of burn patients.
Topics: Anti-Infective Agents, Local; Bacterial Infections; Burns; Candidiasis; Gentamicins; Humans; In Vitr | 1976 |
Acute leukopenia as an allergic reaction to silver sulfadiazine in burn patients.
Topics: Acute Disease; Administration, Topical; Adult; Burns; Drug Hypersensitivity; Female; Humans; Leukope | 1976 |
Immediate management of the burned patient.
Topics: Antisepsis; Burns; Fluid Therapy; Humans; Skin Transplantation; Sulfadiazine; Wound Infection | 1992 |
Silver sulphadiazene: an adjunct to central line maintenance protocol.
Topics: Burns; Catheterization, Peripheral; Humans; Phlebitis; Silver Sulfadiazine; Sulfadiazine | 1990 |
Systemic absorption of sulphadiazine, silver sulphadiazine and sodium sulphadiazine through human burn wounds.
Topics: Absorption; Administration, Topical; Adult; Burns; Female; Humans; Male; Middle Aged; Silver Sulfadi | 1990 |
[Dermazin in the treatment of burns--a clinical study].
Topics: Adolescent; Adult; Aged; Burns; Child; Child, Preschool; Female; Humans; Infant; Male; Middle Aged; | 1990 |
Antibacterial creams for the treatment of burns in infants and toddlers.
Topics: Burns; Burns, Electric; Child, Preschool; Humans; Infant; Ointments; Silver Sulfadiazine; Sulfadiazi | 1988 |
[Experiences on application of a silver sulphadiazine-methylene blue cream for tangential excision and escharotomy of burn wounds].
Topics: Adult; Burns; Drug Combinations; Female; Humans; Male; Methylene Blue; Staining and Labeling; Sulfad | 1985 |
Long-term experience with 1 per cent topical silver sulphadiazine cream in the management of burn wounds.
Topics: Administration, Topical; Bacterial Infections; Burns; Humans; Prospective Studies; Pseudomonas aerug | 1989 |
[Serum and tissue silver levels after burns treated with silver compounds].
Topics: Administration, Topical; Animals; Burns; Kidney; Liver; Rabbits; Silver; Silver Nitrate; Silver Sulf | 1989 |
Second- and third-degree burns as a complication in breast reconstruction.
Topics: Adult; Burns; Female; Humans; Mastectomy; Middle Aged; Patient Education as Topic; Sensory Receptor | 1989 |
Assessment of topical therapy of the burn wound with silver sulphadiazine after its use for 15 years in a burn unit.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Burns; Child; Humans; Microbial Sensitivity Test | 1989 |
Chondritis of the burned ear: a preventable complication if ...
Topics: Burns; Cartilage Diseases; Ear Deformities, Acquired; Ear, External; Humans; Pressure; Silver Sulfad | 1989 |
Use of topically applied silver sulphadiazine plus cerium nitrate in major burns.
Topics: Administration, Cutaneous; Adult; Aged; Anti-Infective Agents, Local; Bandages; Body Surface Area; B | 1989 |
Adverse reaction to sulphonamides in a burned patient--a case report.
Topics: Adult; Anti-Infective Agents, Urinary; Burns; Drug Combinations; Drug Eruptions; Humans; Male; Patch | 1985 |
Combined use of topical cyclosporin A and silver sulphadiazine on allografts infected with Pseudomonas in burned rats.
Topics: Administration, Topical; Animals; Burns; Cyclosporins; Drug Therapy, Combination; Graft Rejection; M | 1987 |
[The effect of pyridonic acid derivatives as topical antibiotics on the prevention and treatment of pyocyaneous infection following burn].
Topics: Administration, Topical; Animals; Burns; Male; Mice; Norfloxacin; Pseudomonas Infections; Rabbits; S | 1987 |
[Experiences with the use of cerium nitrate silver sulfadiazine in the local treatment of thermal injuries in childhood].
Topics: Anti-Infective Agents, Local; Burns; Cerium; Child; Drug Combinations; Humans; Ointments; Silver Sul | 1988 |
A laboratory method to evaluate formulation effects on the in vitro antimicrobial activity of topical creams and ointments.
Topics: Burns; Candidiasis, Cutaneous; Dose-Response Relationship, Drug; Drug Compounding; Escherichia coli | 1987 |
Transient leukopenia associated with topical silver sulfadiazine in burn therapy.
Topics: Burns; Humans; Leukopenia; Silver Sulfadiazine; Sulfadiazine | 1987 |
Leukopenia secondary to silver sulfadiazine: frequency, characteristics and clinical consequences.
Topics: Adolescent; Adult; Aged; Burns; Child; Child, Preschool; Female; Humans; Infant; Leukocyte Count; Le | 1987 |
Topical silver sulphadiazine and profound neutropenia in a burned child.
Topics: Administration, Topical; Agranulocytosis; Burns; Female; Humans; Infant; Neutropenia; Silver Sulfadi | 1986 |
Serum and urinary silver levels in thermal injury patients.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Burns; Humans; Middle Aged; Silver Sulfadia | 1987 |
Synergistic action of silver sulfadiazine and sodium piperacillin on resistant Pseudomonas aeruginosa in vitro and in experimental burn wound infections.
Topics: Administration, Topical; Animals; Burns; Culture Media; Drug Synergism; Female; Mice; Penicillin Res | 1985 |
[Experimental study of topical antimicrobial agents in burns].
Topics: Animals; Anti-Infective Agents, Local; Burns; Male; Niacin; Pipemidic Acid; Rabbits; Sulfadiazine | 1985 |
[Hypersensitivity due to topical use of silver sulfadiazine on burn wounds (report of 6 cases)].
Topics: Adolescent; Adult; Burns; Drug Hypersensitivity; Female; Humans; Male; Sulfadiazine | 1985 |
Hyperosmolality induced by propylene glycol. A complication of silver sulfadiazine therapy.
Topics: Administration, Topical; Burns; Heart Arrest; Humans; Infant; Male; Ointment Bases; Osmolar Concentr | 1985 |
Tissue deposition of silver following topical use of silver sulphadiazine in extensive burns.
Topics: Administration, Topical; Adult; Burns; Gingiva; Humans; Male; Middle Aged; Mouth Mucosa; Silver Sulf | 1985 |
The clinical consequences of an industrial aerosol plant explosion.
Topics: Accidents, Occupational; Adolescent; Adult; Aerosols; Blast Injuries; Burns; Clothing; Disaster Plan | 1985 |
The human pharmacology of silver sulphadiazine (AgSD)
Topics: Administration, Topical; Animals; Burns; Humans; Pseudomonas Infections; Silver Sulfadiazine; Sulfad | 1985 |
Bacteriological effect of cerium-flamazine cream in major burns.
Topics: Administration, Topical; Adolescent; Adult; Bacterial Infections; Burns; Cerium; Chlorhexidine; Drug | 1985 |
Prospective study of side effects associated with the use of silver sulfadiazine in severely burned patients.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antibodies; Antigen-Antibody Complex; Burns; Child | 1985 |
Drug-loaded synthetic dressings: effect on contraction, epithelialization, and collagen synthesis of deep second-degree experimental burns.
Topics: Animals; Bandages; Burns; Collagen; Epithelium; Female; Guinea Pigs; Silver Sulfadiazine; Skin; Sulf | 1985 |
Topical treatment of burns.
Topics: Anti-Infective Agents, Local; Biguanides; Burns; Drug Synergism; Evaluation Studies as Topic; Humans | 1971 |
Local treatment of burns.
Topics: Acetates; Air; Burns; Hot Temperature; Humans; Humidity; Ointments; Pain; Silver; Silver Nitrate; Su | 1971 |
Survival with ecthyma gangrenosum, a previously fatal complication of burns.
Topics: Aminoglycosides; Anti-Bacterial Agents; Burns; Carbenicillin; Child, Preschool; Colistin; Ecthyma; F | 1974 |
Parenteral nutrition in the burned child: a study of twenty-six patients.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Body Surface Area; Body Weight; Burns; Cath | 1974 |
The continuing problem of sepsis-following enzymatic debridement of burns.
Topics: Adolescent; Bacillus subtilis; Burns; Child; Child, Preschool; Clostridium; Debridement; Escherichia | 1974 |
Evaluation of topical povidone-iodine ointment in experimental burn wound sepsis.
Topics: Animals; Autopsy; Biopsy; Burns; Evaluation Studies as Topic; Liver; Lung; Male; Povidone; Pseudomon | 1974 |
The treatment of burns in the recent Middle East conflict.
Topics: Acute Kidney Injury; Adolescent; Adult; Anesthesia, Inhalation; Animals; Burns; Debridement; Facial | 1974 |
Experimental burn wound sepsis--evaluation of enzymatic debridement.
Topics: Animals; Bacillus subtilis; Burns; Debridement; Drug Evaluation; Drug Therapy, Combination; Endopept | 1974 |
Burns and the use of silver sulphadiazine.
Topics: Adolescent; Adult; Aged; Burns; Child; Child, Preschool; Costs and Cost Analysis; Enterobacteriaceae | 1972 |
Local and systemic therapy of pseudomonas septicemia in burned mice.
Topics: Animals; Anti-Bacterial Agents; Burns; Chloramphenicol; Colistin; Gentamicins; In Vitro Techniques; | 1967 |
[Effect of collagenase on the necrolysis of burn wounds delayed by antibiotic therapy].
Topics: Animals; Burns; Microbial Collagenase; Necrosis; Silver; Silver Nitrate; Sulfadiazine; Sulfanilamide | 1972 |
Management of the acute burn patient--1973.
Topics: Airway Obstruction; Burns; Gentamicins; Humans; Hypertonic Solutions; Infusions, Parenteral; Neomyci | 1973 |
Evaluation of a new topical agent for burn therapy. Silver sulfadiazine (silvadene).
Topics: Administration, Topical; Bacteria; Bacterial Infections; Burns; Drug Evaluation; Drug Resistance, Mi | 1974 |
Burns - a case history.
Topics: Adult; Burns; Humans; Hydrotherapy; Male; Patient Isolators; Physical Therapy Modalities; Silver; Su | 1974 |
Topical therapy of burns in children with silver sulfadiazine.
Topics: Adolescent; Burns; Child; Child, Preschool; Humans; Infant; Ointments; Silver; Sulfadiazine; Time Fa | 1973 |
Topical therapy of burns.
Topics: Anti-Infective Agents; Burns; Child; Debridement; Gentamicins; Humans; Pseudomonas Infections; Skin | 1972 |
Delayed primary excision and skin grafting of the burned hand.
Topics: Bacteria; Burns; Granulation Tissue; Hand Injuries; Humans; Occlusive Dressings; Postoperative Care; | 1973 |
Proceedings: Improved management of skin graft donor sites.
Topics: Abdomen; Arm; Back; Burns; Buttocks; Child; Debridement; Humans; Leg; Nitrofurazone; Organ Specifici | 1974 |
Chemical debridement of burns.
Topics: Animals; Bromelains; Burns; Debridement; Dogs; Female; Hematocrit; Male; Rats; Skin Transplantation; | 1974 |
Use of silver sulphadiazine in the treatment of burns at Royal Perth Hospital.
Topics: Adult; Burns; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Ski | 1972 |
Experimental burn wound sepsis: variations in response to topical agents.
Topics: Animals; Anti-Infective Agents, Local; Burns; Lactates; Male; Pseudomonas aeruginosa; Pseudomonas In | 1972 |
Infection control in burns. Topical and systemic.
Topics: Adult; Bandages; Burns; Carbenicillin; Child; Female; Gentamicins; Humans; Infant; Male; Penicillins | 1972 |
Silver sulphadiazine in the control of infection in burns.
Topics: Bacterial Infections; Burns; Humans; Silver Nitrate; Sulfadiazine | 1973 |
Sliver sulfadiazine.
Topics: Anti-Infective Agents, Local; Burns; Humans; Silver; Sulfadiazine; Wound Infection | 1974 |
Care of the burned hand.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Bandages; Burns; Gloves, Surgical; Hand Injuries; Hum | 1974 |
Progress in the treatment of burned children.
Topics: Anti-Bacterial Agents; Burns; Cadaver; Child; Granulation Tissue; Humans; Legislation, Medical; Pati | 1970 |
Current problems in burns. A perspective.
Topics: Accident Prevention; Burns; Clothing; Colloids; Duodenal Ulcer; Fires; Gentamicins; Humans; Infusion | 1971 |
The burn wound and its care.
Topics: Burns; Gentamicins; Humans; Sepsis; Silver Nitrate; Skin Transplantation; Sulfadiazine; Sulfonamides | 1971 |
Management of patients with thermal injuries.
Topics: Adolescent; Adult; Aged; Alabama; Animals; Bandages; Burns; Child; Child, Preschool; Female; Humans; | 1971 |
Treatment of burns today.
Topics: Acid-Base Equilibrium; Blood Gas Analysis; Body Weight; Burns; Central Venous Pressure; Colloids; Di | 1971 |
Evaluation of a synthetic bioadherent dressing as a temporary skin substitute.
Topics: Animals; Bandages; Burns; Granulation Tissue; Nylons; Peptides; Prostheses and Implants; Skin; Skin | 1971 |
V. Systemic and local infection and immunity. The role of bacteria in burn mortality.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Burns; Endotoxins; Escherichia coli; Female; Germ-Free Lif | 1968 |
Chemotherapy of pseudomonas septicaemia in burned mice: systemic therapy with streptomycin and sulphonamides.
Topics: Animals; Burns; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Streptomycin; Sulfadia | 1968 |
Virulence of Pseudomonas infection in burned rats and mice. Comparative efficacy of silver sulfadiazine and mafenide.
Topics: Animals; Burns; Culture Techniques; Heart; Mice; Ointments; Pseudomonas aeruginosa; Pseudomonas Infe | 1970 |
Immunological control of Pseudomonas infection in burn patients: a clinical evaluation.
Topics: Adolescent; Anti-Infective Agents, Local; Antibody Formation; Bacterial Vaccines; Burns; Child; Fema | 1971 |
Panel discussion: some thoughts on the care of the burned patient, 1972.
Topics: Bacterial Infections; Bandages; Burns; Gentamicins; Humans; Physical Therapy Modalities; Silver; Sil | 1972 |
Control of infection following burn injury.
Topics: Anti-Bacterial Agents; Burns; Catheterization; Gentamicins; Humans; Immunotherapy; Pseudomonas Infec | 1971 |
Chlorhexidine with silver-sulphadiazine in the treatment of burns.
Topics: Anti-Infective Agents, Local; Biguanides; Burns; Drug Synergism; Humans; Silver; Sulfadiazine | 1971 |
Alternate case study of topical sulfamylon and silver sulfadiazine in burns.
Topics: Acidosis; Adolescent; Adult; Anemia; Burns; Child; Child, Preschool; Female; Humans; Male; Pseudomon | 1971 |
Topical chemoprophylaxis for burns: trials of creams containing silver sulphadiazine and trimethoprim.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Burns; Child; Child, Preschool; Drug Resistance, Mic | 1971 |
Effect of silver lactate and silver sulfadiazine on experimental burn wound sepsis.
Topics: Allantoin; Animals; Burns; Lactates; Pseudomonas Infections; Rats; Rats, Inbred Strains; Sepsis; Sil | 1971 |
Gentamicin for septicemia in patients with burns.
Topics: Adolescent; Blood Urea Nitrogen; Burns; Candida; Child; Child, Preschool; Drug Synergism; Endotoxins | 1971 |
Silver sulfadiazine cream in the management of burns.
Topics: Adult; Anti-Infective Agents, Local; Burns; Child; Female; Humans; Male; Ointments; Silver; Sulfadia | 1970 |
Possible deleterious effects of topical agents on the rate of healing on the burn wound.
Topics: Acetates; Air; Animals; Burns; Dermatologic Agents; Guinea Pigs; Occlusive Dressings; Regeneration; | 1969 |
Silver sulfadiazine and Sulfamylon cream in the burned rat model: a comparative evaluation.
Topics: Animals; Burns; Disease Models, Animal; Hydrogen-Ion Concentration; Liver; Lung; Ointments; Pharmace | 1970 |
Topical and systemic antibacterial agents in the treatment of burns.
Topics: Anti-Infective Agents; Anti-Infective Agents, Local; Bandages; Burns; Debridement; Gentamicins; Huma | 1970 |
Contact dermatitis to mafenide acetate.
Topics: Aged; Antigens; Binding Sites; Burns; Dermatitis, Contact; Female; Humans; Male; Middle Aged; Skin T | 1971 |
Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns.
Topics: Aminobenzoates; Animals; Anti-Infective Agents, Local; Burns; Humans; Mice; Nitrobenzenes; Ointments | 1968 |
Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infections in burns.
Topics: Adult; Animals; Anti-Infective Agents, Local; Burns; Child; Female; Humans; Male; Mice; Military Med | 1969 |
Control of pseudomonas infection in burns by silver sulfadiazine.
Topics: Adult; Animals; Burns; Cephalothin; DNA; DNA, Bacterial; Female; Guinea Pigs; Humans; Mice; Military | 1969 |
Mafenide (Sulfamylon) and other topical agents for severe burns.
Topics: Anti-Infective Agents, Local; Bacteria; Burns; Gentamicins; Humans; Ointments; Sulfadiazine; Toluene | 1969 |
A procedure for measurement of wound healing, with special reference to burns.
Topics: Animals; Anti-Bacterial Agents; Burns; Chloramphenicol; Gentamicins; Mice; Neomycin; Pseudomonas Inf | 1966 |